Survival outcomes based on systemic agent used concurrently with radiation in human-papillomavirus associated oropharyngeal cancer

PURPOSE: To investigate survival outcomes of patients treated with concurrent cetuximab and radiotherapy for primary management of both HPV positive and negative OPSCC, and compare the results to traditional platinum-based therapy. We hypothesize that the use of cetuximab in the HPV positive OPSCC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Vikas, Moore-Medlin, Tara, Flores, Jose M., Ma, Xiaohui, Ekshyyan, Oleksandr, Nathan, Cherie-Ann O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642607/
https://www.ncbi.nlm.nih.gov/pubmed/29050332
http://dx.doi.org/10.18632/oncotarget.20197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642607/
https://www.ncbi.nlm.nih.gov/pubmed/29050332
http://dx.doi.org/10.18632/oncotarget.20197

Ejemplares similares